Want to stay up-to-date on the science and politics driving biotechnology today? Sign up to receive our biotechnology newsletter in your inbox.
We’ve got all the latest information on the huge news that was announced late yesterday. CBER Director George Tidmarsh resigned from the FDA following an investigation sparked by allegations from a former collaborator and infighting within the agency.
Pfizer also sued Novo Nordisk in an attempt to block its acquisition of obesity biotech Metsera.
This article is available to STAT+ subscribers only.
Unlock this article and also receive in-depth analysis, newsletters, premium event and news alerts.
Already have an account? log in
See all plans
